Scandinavian Real Heart AB (Publ) (STO:HEART)
Sweden
· Delayed Price · Currency is SEK 17.95
+0.20 (1.13%)
Apr 29, 2026, 10:18 AM CET
STO:HEART Revenue
In the year 2025, Scandinavian Real Heart AB (Publ) had annual revenue of 153.10K SEK with 7,832.54% growth. Scandinavian Real Heart AB (Publ) had revenue of 76.55K in the quarter ending December 31, 2025, a decrease of -277.61%.
Revenue
153.10K
Revenue Growth
+7,832.54%
P/S Ratio
985.22
Revenue / Employee
10.94K
Employees
15
Market Cap
150.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 153.10K | 151.17K | 7,832.54% |
| Dec 31, 2024 | 1.93K | 1.99K | -3,212.90% |
| Dec 31, 2023 | -62.00 | -10.06K | -100.62% |
| Dec 31, 2022 | 10.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boule Diagnostics AB | 489.69M |
| Clinical Laserthermia Systems AB | 17.49M |
| Nosa Plugs AB | 23.91M |
| Iconovo AB | 13.82M |
| Neola Medical AB | 8.28M |
| Arcoma AB | 126.93M |
| Promimic AB | 51.06M |
| Integrum AB | 98.18M |